Cancer Genomics & Metabolomics

Oncogenomics is a field in genomics which characterize cancer-associated  genes. Its main focus includes genomic, epigenomic and transcript alterations in cancer. The main concept and idea of oncogenomics is to check new group of oncogenes or tumour suppressor genes that may give new areas of research into cancer diagnosis, predicting clinical outcome of cancer treatment and new targets for cancer therapies. The GleevecHerceptin and Avastin are the targeted cancer therapies which gave a new way for oncogenomics to elucidate new targets for cancer treatment. Metabolomics is a newly emerging field in 'omics' research and refers to the complete set of small-molecule metabolites, which gives the systematic study of unique chemical fingerprints that leaves cellular processes behind. The metabolome represents the collection of all metabolites in a biological cell, tissue, organ or an organism that are the end products of cellular processes. Metabolic profiling gives an instantaneous snapshot of the physiology of given cell. One of the challenging aspects of system biology and functional genomics is to integrate proteomic, transcriptomic and metabolomic information which provide a better understanding of cellular biology.

  • Track 1-1 Epigenomic
  • Track 2-2 Cancer Genomics
  • Track 3-3 Genome-Wide Methylation Arrays
  • Track 4-4 Transcriptomics and Proteomics
  • Track 5-5 Metabolite Profiling
  • Track 6-6 Diagnostic Tools

Related Conference of Hematology